This was disclosed by Mr. Sushil Suri, Chairman and Managing Director, Morepen Laboratories Ltd. after the company’s board meeting, which discussed and took on record the fourth quarter and annual results of the company for the financial year 2015-16. “After attaining leadership in Loratadine, by being world’s largest generic supplier of the bulk drug, Morepen Laboratories Ltd. has attained a leadership in its second molecule -Montelukast,” he pointed out.
A brief presentation on Divi's Lab a listed CRAMS company. This presentation gives an overview of the company covering its business, valuation, SWOT, Comparative analysis, Industry, FDA Details
How Mankind grew and made it in top 5 pharma companies. Mankind Pharma is a pharmaceutical company in India based at New Delhi. The company has products in therapeutic areas ranging from unds, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications
A brief presentation on Divi's Lab a listed CRAMS company. This presentation gives an overview of the company covering its business, valuation, SWOT, Comparative analysis, Industry, FDA Details
How Mankind grew and made it in top 5 pharma companies. Mankind Pharma is a pharmaceutical company in India based at New Delhi. The company has products in therapeutic areas ranging from unds, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications
Jordan-based global pharmaceutical Hikma has transformed its delivery of compliance training with a new cloud-based technology that engages and educates employees.
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
Mankind was established in 1991, almost a decade after the industry leaders of today including Dr.Reddy’s and Sun Pharma, but has grown considerably faster than its contemporaries...
One reason for this is that unlike major drug makers who have a large portfolio of hundreds of products, mankind prefers to concentrate on a much smaller number of high value products. “they don’t bother with smaller products with a potential value of less than Rs.5 crore,” says a long-time industry watcher. thus Health OK, their OTC product, which is a combination of vitamins and nutritional medicines was able to generate Rs.50 crore in revenue within a year of its launch in 2014-15.
This is also the approach adopted by some multinationals like Sanofi, whose CEO Chris Viebacher said, that his company obtained a lion’s share of its revenue from just 15 top selling patented products...
Mergers & Acquisitions in Pharmaceutical SectorAnjali Mehra
This report highlights the structure, regulatory framework, top market players etc. of the Indian Pharmaceutical Industry and presents a review of major Mergers and Acquisitions in Indian pharmaceutical industry and the reasons of the said mergers and acquisitions.
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...Saurabh
CHL is our typical Multibagger stock, but a Stock which is a Good Investment under current Market conditions. It has a presence in a space which offers enormous potential and is also trading at reasonable valuations which will deliver superior returns in the long run.
Core Investment Thesis :
The company is in healthcare space and is one of the fastest growing pharma companies among top-10 domestic peers. It currently ranks as the 4th largest pharmaceutical company in India with a market share of ~4.2%, based on domestic sales of formulations.
Sun Pharma - Ranbaxy Merger PresentationDeepak Shenoy
SunPharma and Ranbaxy merge in 2014 to create India's largest and the world's fifth largest pharma company. The merger, which is all stock, will give Ranbaxy shareholders 0.8 Sun Pharma shares for each share they own.
Pharmaceuticals Industry Analysis with analysis of Top notch Companies in pharmaceuticals viz. Sun pharma, Lupin, Dr. Reddy's Laboratory, Cipla, Aurobindo Pharma to identify opportunity to invest in equity share of these companies.
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
Some things will always remain unfettered. Like sunshine and air, like suffering and joy, like sharing and caring. Some things will never recognize the confines of space and time. Like human endeavour and enterprise, like the desire to touch life. At Morepen, we are taking our expertise and experience in Wellness to new countries and new people with an increasing focus on global exports. And in doing so, our spirit of caring is crossing boundaries.
Jordan-based global pharmaceutical Hikma has transformed its delivery of compliance training with a new cloud-based technology that engages and educates employees.
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
Mankind was established in 1991, almost a decade after the industry leaders of today including Dr.Reddy’s and Sun Pharma, but has grown considerably faster than its contemporaries...
One reason for this is that unlike major drug makers who have a large portfolio of hundreds of products, mankind prefers to concentrate on a much smaller number of high value products. “they don’t bother with smaller products with a potential value of less than Rs.5 crore,” says a long-time industry watcher. thus Health OK, their OTC product, which is a combination of vitamins and nutritional medicines was able to generate Rs.50 crore in revenue within a year of its launch in 2014-15.
This is also the approach adopted by some multinationals like Sanofi, whose CEO Chris Viebacher said, that his company obtained a lion’s share of its revenue from just 15 top selling patented products...
Mergers & Acquisitions in Pharmaceutical SectorAnjali Mehra
This report highlights the structure, regulatory framework, top market players etc. of the Indian Pharmaceutical Industry and presents a review of major Mergers and Acquisitions in Indian pharmaceutical industry and the reasons of the said mergers and acquisitions.
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...Saurabh
CHL is our typical Multibagger stock, but a Stock which is a Good Investment under current Market conditions. It has a presence in a space which offers enormous potential and is also trading at reasonable valuations which will deliver superior returns in the long run.
Core Investment Thesis :
The company is in healthcare space and is one of the fastest growing pharma companies among top-10 domestic peers. It currently ranks as the 4th largest pharmaceutical company in India with a market share of ~4.2%, based on domestic sales of formulations.
Sun Pharma - Ranbaxy Merger PresentationDeepak Shenoy
SunPharma and Ranbaxy merge in 2014 to create India's largest and the world's fifth largest pharma company. The merger, which is all stock, will give Ranbaxy shareholders 0.8 Sun Pharma shares for each share they own.
Pharmaceuticals Industry Analysis with analysis of Top notch Companies in pharmaceuticals viz. Sun pharma, Lupin, Dr. Reddy's Laboratory, Cipla, Aurobindo Pharma to identify opportunity to invest in equity share of these companies.
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
Some things will always remain unfettered. Like sunshine and air, like suffering and joy, like sharing and caring. Some things will never recognize the confines of space and time. Like human endeavour and enterprise, like the desire to touch life. At Morepen, we are taking our expertise and experience in Wellness to new countries and new people with an increasing focus on global exports. And in doing so, our spirit of caring is crossing boundaries.
Aarti Drugs (ADL) is a part of well known Aarti group of industries. The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also manufactures formulations through its wholly-owned subsidiary- Pinnacle Life Science Private Limited.
The company has a long standing track record in the bulk drugs industry and has been supplying products to demanding domestic and international customers.
With the help of Dr. Morepen Sushil suri, Morepen Labs' standalone net profit...Morepen
Morepen Laboratories has posted strong growth of 179 per cent in standalone net profit during the fourth quarter ended March 2017 to Rs. 7.72 crore from Rs. 2.77 crore in the corresponding period of last year. Its net sales increased by 15.7 per cent to Rs. 142.95 crore from Rs. 123.59 crore. Interest cost declined significantly to Rs. 0.66 crore from Rs. 2.68 crore.
Iol chemicals and pharmaceuticals multibagger 2021 & SIGN-UP new multibagger...futurecapsadvisor
Sign-up for free !! To get your first free multibagger. Wealth is the ability to fully experience life. Visit the link below !!
..
#multibagger #stockmarcket #futurecaps #investindia
Morepen labs profit up | Under Dynamic Leadership of Sushil Suri CBImorepen
New Delhi, May 1 (UNI) Morepen Laboratories Limited has reported a 179 per cent rise in its net profit at Rs 7.73-crore and 17.4 per cent rise in its net sales revenue at Rs 141-crore in the fourth quarter (Q4) of fiscal 2016-17.
The net profit and the net sales revenue stood at Rs 2.77-crore and Rs 119.77-crore in the corresponding quarter of the fiscal 2015-16.
ALPM is a leading pharmaceutical
company in India at present. Starting 1940, Alembic
Pharma transformed into a pharma focused company
engaged in manufacturing of cough syrups, vitamins,
tonics and sulphur drugs. The Company is vertically
integrated with the ability to develop, manufacture and
market pharmaceutical products, pharmaceutical
substances and intermediates. The Company possesses
manufacturing facilities at Panelav in Gujarat
(USFDA-approved for APIs and formulations),
Karkhadi, Gujarat (USFDA-approved for API) and
Baddi in Himachal Pradesh (manufactures
formulations for Indian and emerging markets).
Morepen inks pact with vésale pharma to boost presence in rs 1000morepen
NEW DELHI: Indian pharmaceutical firm Morepen LaboratoriesBSE -0.24 % Ltd, listed on the Bombay Stock Exchange, has inked an exclusive agreement to market and distribute Belgian probiotics player Vesale Pharma International's major brands in the gastroenterology segment—a deal it hopes will help it strengthen its presence in India's growing probiotics market.
Export Potentiality of Pharmaceutical goods in BangladeshHr Shamim
The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. The World Trade Organization's (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement permits Bangladesh to reverse-engineer patented generic pharmaceutical products to sell locally and export to markets around the world.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Morepen sushil suri
1. Trending News: Mayur Vihar Andrews Field Didier Deschamps Anton Yelchin Ram Shankar Katheria Álvaro
Morata Namibia Shankar Chaudhary Walt Disney World LIGO JoCox Dunga Anjan Dutta National RifleAssociation Girish
Dattatray Mahajan
Search
Advertisements
Advertisement
Designer Rakhi with Roli &Chawal -
₹146.00
AMAZON
Pendant in 925 Sterling Silver Shankh
Charm in Gold byfourseven Unisex-
₹700.00
AMAZON
Skmei Analogue-Digital Black Dial Men"s
Watch - 1031 - ₹685.00
AMAZON
Neon Silicone Chiclet Keyboard Protector
INDIA-DELHI-NEW DELHI DT:11-05-2016 11:56AM
Business Wire India
Morepen Laboratories Ltd. has established a leadership position for its anti-asthmatic bulk drug
Montelukast in the global market. As per the latest report published by a global research firm -
QYR Research, Morepen is the No.1 supplier globally in terms of total quantity sold, followed by
Mylan and TAPI(Teva) who appear on the second and third position respectively.
Morepen’s global sales for Montelukast Sodium stood at 16240 kgs in the calender year 2015,
resulting in a market share of 23 per cent (approx.) compared to Mylan’s and Teva’s 12 per cent
each, the report claims.
This was disclosed by Mr. Sushil Suri, Chairman
and Managing Director, Morepen Laboratories
Ltd. after the company’s board meeting, which
discussed and took on record the fourth quarter
and annual results of the company for the financial
year 2015-16. “After attaining leadership in
Loratadine, by being world’s largest generic
supplier of the bulk drug, Morepen Laboratories
Ltd. has attained a leadership in its second
molecule -Montelukast,” he pointed out.
Morepen Laboratories Ltd. has reported an over
25-fold increase in its net profit for the financial
year ended March 31, 2016. The net profit
increased from Rs. 58 lakhs in FY2014 -15 to Rs.
15.78 crore in FY2015-16. The total operating
revenue in FY2015-16 stood at Rs. 452.46 crore as against Rs. 370.26 crore in the previous
fiscal, registering a growth of 22.20 per cent.
For the fourth quarter ended March 31, 2016, net profit rose to Rs. 2.77 crore on a total operating
revenue of Rs. 123.59 crore as compared to a loss of Rs. 3.72 crore on a total operating revenue
of Rs. 85.36 crore in the corresponding quarter of the previous fiscal.
Morepen’s EBIDTA increased by 36.30 per cent in fiscal 2015-16 at Rs. 65.38 crore and the
cash surplus (i.e. EBDTA) rose by 40 per cent at Rs. 54.96 crore compared to Rs. 47.95 crore
and Rs. 39.31 crore respectively, in the previous fiscal.
“Enhanced focus on cost reduction and adoption of innovative processes resulted in
this remarkable turnaround, putting the company back on the profit trajectory,” Mr. Suri
said.
Q4 marked excellent performance in all business segments particularly bulk drugs (API) which
has grown by more than 50%, while Home Diagnostics and Finished Dosages segments also
outperformed and registered a remarkable growth of 35% and 40% respectively adding to the
outstanding quarterly performance.
Morepen Laboratories Scores No. 1 Position Globally for its
Bulk Drug Montelukast
Morepen Laboratories Ltd. has established a leadership position for its anti-asthmatic bulk
drug Montelukast in the global market. As per the latest ...
Parallel Universe(TM) Micro USBto USB
type C (USB3.1) adapter for HTC 10,
Lenovo Zuk Z1, Le 2, Le Max2, Oneplus
3, Xiaomi Mi5, Le Eco Le 1s, Oneplus
Two, Nexus 5X, Nexus 6P, Macbook Air,
Chromebook,etc with Charging and data
transfer between PC and Phone. [Does
not support OTG] - ₹164.00
AMAZON
BlueRigger High Speed HDMI Cable with
Ethernet - Supports 3D, 4Kand Audio
Return - Latest Version (6.6 Feet / 2
Meters) - ₹143.00
NEWS REGIONAL POLITICS MOVIES SPORTS LANGUAGES GALLERY VIDEOS iWON HOLLYWOOD TECH
converted by Web2PDFConvert.com